US Healthcare: Why Copying Europe's 'Socialism' is So Terrifying
The article delicately tiptoes around the obvious: Europe’s generally more affordable healthcare models involve public funding and reduced private profit. This isn't groundbreaking foreign policy; it’s widely accepted practice outside the American 'market.' The real obstacle isn't a lack of knowledge, but a lobbying behemoth. In 2023 alone, the US pharmaceutical and health products industry spent
over $380 million on lobbying, while hospitals and nursing homes threw in another $100 million. (OpenSecrets.org: Pharma/Health Products $381,673,348, Hospitals $111,260,266 in 2023). So, when politicians preach the impossibility of universal healthcare, one might wonder if it’s genuinely impossible, or merely impossible for them to accept fewer donations from the industry writing America's
medical bills. It appears the 'cost crisis' isn't baffling; it's a feature, not a bug, of a system optimized for shareholder returns over patient well-being. Perhaps Europe's secret ingredient isn't complex, just unwelcome.